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Abstract 
 This study examined the occurrence of phlebitis, infiltration, and 
localized site infection between standard replacement (control group) and 
clinically indicated replacement (experimental group) among patients with 
peripheral IV catheters. We utilized a two-group, post-test only, randomized 
experimental design in a level 4 tertiary hospital in Cebu for a period of 30 
days. A total of 80 participants who passed the selection criteria were chosen 
and equally divided into 2 groups of 40 members each using randomization. 
The control group had their peripheral IV catheters changed every 3 days 
while the experimental group had their peripheral IV catheters replaced only 
in the presence of complications. The outcome variables for the study were 
phlebitis, infiltration, and localized site infection. Findings revealed that the 
standard replacement group had a higher prevalence rate of complications 
compared to the clinically indicated replacement group. Moreover, patients 
who stayed for 7-14 days had an increased likelihood of developing phlebitis 
and infiltration compared to those who remained for 4-6 days. Remarkably, 
peripheral IV catheters inserted by physicians had a higher rate of infiltration 
compared to nurses. Furthermore, nurses who had 2 years of experience were 
found to have lower incidence of phlebitis compared to those who had 3 
years of experience. In conclusion, the risk of developing phlebitis and 
infiltration was not increased when peripheral IV catheters were replaced on 
a clinical-need rather than on a routine basis. Hospitals should consider 
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adopting new guidelines wherein peripheral IV catheters are changed only in 
the presence of complications. 
 
Keywords: Peripheral intravenous catheters, standard replacement, clinically 
indicated replacement, phlebitis, infiltration, localized site infection 
 
Introduction 
 Intravenous (IV) therapy involves the administration of medications 
through a catheter inserted either peripherally or centrally. Indications for 
intravenous therapy include administration of intravenous medications and 
fluids, giving of parenteral nutrition, and provision of blood and blood 
products during acute, perioperative, and emergency situations (Waitt, Waitt, 
& Pirmohamed, 2004; Dychter, Gold, Carson, & Haller, 2012).  
 By the 1990s, greater than 85 percent of inpatients in the US received 
IV therapy (Dychter et al., 2012). Today, approximately 200 million 
peripheral IV catheters are used yearly in the US alone (Maki, 2008). Since 
intravenous cannulation is an invasive procedure, it may serve as a port for 
pathogens to enter into the local tissues or bloodstream. Although the 
percentage of bloodstream infections linked with peripheral IV catheters is 
generally small, with its increased usage, serious infectious complications 
could result in morbidity. Common complications arising from the presence 
of peripheral IV catheters include: phlebitis, infiltration, extravasation 
(Dougherty & Lister, 2005), and localized site infection if left in place for 
>72 hours (O’Grady, 2002). To minimize the complications, the Center for 
Disease Control and Prevention (CDC) endorses in its 2011 
recommendations, the routine change of peripheral IV catheters every 3-4 
days in adults (CDC, 2011). Conversely, the Infusion Nurses Society (INS) 
recommends the rotation of peripheral IV catheters on a clinical need basis in 
its 2011 standards (INS, 2011). Thus, the issue of when to change the 
peripheral IV catheters remains unresolved as of today. 
 Furthermore, it is important to note that new punctures not only cause 
inconvenience for the patient but also add to the hospital expenses. A recent 
study revealed that clinically indicated catheter changes is more economical 
compared with routine replacement (Tuffaha et al., 2014). Likewise, Rickard 
et al (2012) showed the possibility of replacing peripheral IV catheters only 
in the presence of complications. 
 In the Philippines, the Association of Nursing Service Administrators 
of the Philippines (ANSAP) is the recognized body of the Professional 
Regulation Commission (PRC) to conduct the training on intravenous 
therapy. Since ANSAP is a member of the INS, it is only but natural that 
ANSAP follows the 2011 INS standards. In spite of that, there are still 
practices in both private and public hospitals in the country that advocates 
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routine or standard peripheral IV catheter changes every 3 days or 72 hours. 
Thus, there is a need to investigate the unsettled matter of the ideal time to 
change the peripheral IV catheters in adults.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1 shows the framework of the study and the relationship 
between the independent and dependent variables. The research participants 
were equally distributed into two (2) groups – the standard replacement 
(control) and the clinically indicated replacement (experimental) – and were 
subjected to a two-group, post-test only, randomized experimental design. 
The four (4) moderating and eleven (11) mediating variables were taken into 
consideration and were measured according to the degree of influence they 
exert on the independent and dependent variables. Outcome or dependent 
variables for the study are phlebitis, infiltration, and localized site infection. 
Findings of the research would be used to propose new intravenous (IV) 
replacement guidelines.  
 
Study Objectives 
 This study examined the occurrence of phlebitis, infiltration, and 
localized site infection between standard replacement and clinically indicated 
replacement groups among patients with peripheral IV catheters. 
Specifically, it endeavored to determine (1) the prevalence rates of phlebitis, 
infiltration, and localized site infection in both groups, (2) which of the 
following factors relate with the outcome variables (ward, age, gender, 
 
Figure 1. Conceptual schema of the study 
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length of hospital stay, diagnosis, number of comorbidities, profession and 
experience as IV therapist, number of cannulation attempts on same vein; 
location and laterality of IV site, IV catheter size and type, type of IV fluid 
and medication received), (3) whether significant difference existed in the 
occurrence of outcome variables (phlebitis, infiltration, and localized site 
infection) between standard replacement and clinically indicated replacement 
groups. Finally, a new IV replacement guideline is proposed for adoption 
and implementation based on the study findings. 
 In this research, we tested the null hypothesis of no significant 
difference in the occurrence of phlebitis, infiltration, and localized site 
infection between standard (control) and clinically indicated (experimental) 
replacement groups.  
 
Significance of the Study 
 The research findings provide insight on the possibility of extending 
the peripheral IV catheter beyond 72 hours or 3 days.  After being deemed 
viable, hospitals need to re-examine their current policy on routine 
replacement of catheters every 3 days.  Furthermore, the significant results of 
the study sheds new light on which IV cannulation policy should be adopted 
– CDC or INS. For healthcare professionals, replacing peripheral IV 
catheters on a clinical need basis saves them a lot of time lost in the 
reinsertion process – most especially if it involves a difficult IV site. Nurses 
and physicians alike can then convert that to more patient interaction and 
care. New puncture sites spell increased costs for patients. Changing 
peripheral IV catheters only when clinically indicated allows patients to 
allocate their savings to more important expenditures (i.e. medications, room 
accommodations, and hospital equipment rentals). In addition, unnecessary 
pain associated with reinserting peripheral IV catheters, even without 
complications, can be avoided.  
 In the same manner, future studies can use the research outcomes to 
explore more benefits or find disadvantages of choosing clinically indicated 
changes over routine reinsertion when it comes to replacement of peripheral 
IV catheters. Moreover, the study encourages other research enthusiasts to 
review other hospital policies with the ultimate goal of improving patient 
care. On a different note, lesser frequency in changing peripheral IV 
catheters means fewer medical wastes; thus, reduced consumption of these 
materials result in better waste management in the community and the 
country as a whole.   
 
Scope and Limitation 
 Even with time constraints and limited funding, we were able to 
cover a period of one month in a tertiary hospital located in Cebu City, 
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Central Philippines. Participants were screened if they were: (a) admitted in 
the Medical or Surgical Ward, (b) 18 years old and above, and (c) projected 
to have a peripheral IV catheter in place for a minimum of 96 hours. Those 
who passed the inclusion criteria were initially counted for the study. After 
which, the participants were assessed if they: (a) were immunocompromised, 
(b) had an IV in place for more than 48 hours, (c) had a planned removal of 
IV in less than 24 hours, (d) underwent blood transfusion using the same IV 
catheter, and (e) had hypersensitivity to the IV catheter. If they had any of 
the 5 exclusion criteria, they were automatically omitted from the study. A 
total of 80 patients who passed the comprehensive selection criteria were 
considered for the study. 
 Routine blood and device cultures were ideally recommended to link 
the incidence of localized site infection to the presence of a peripheral IV 
device. However, these were not possible due to budgetary constraints; 
hence, they were eliminated from the study.  
 
Literature Review 
 The first known documented use of intravenous (IV) therapy dates 
back as early as 1942 where a physician  attempted to give blood transfusion 
to Pope Innocent VIII from three adolescent boys. However, the result was 
dismal since all the donors and the recipient died. It was in the mid-1600s 
that Christopher Wren created the first functional IV infusion apparatus. 
Using a pig’s bladder and a plume, he was able to successfully infuse a 
unique mixture of different elements into the veins of a dog (Rivera, Strauss, 
van Zundert, & Mortier, 2005). When Wren left Oxford to begin his work as 
an architect of churches, his colleague – Richard Lower, took over the 
transfusion studies and made a breakthrough by successfully transfusing 
blood from one dog to another (Felts, 2000). He was later dubbed as the 
Father of IV Therapy.  
 Back in the olden times, there were several attempts of using IV 
therapy to infuse humans with animal blood (Corrigan, 2001). The first 
known successful attempt at human blood transfusion was carried out by Dr. 
James Blundell in 1818 using a syringe (Rivera et al., 2005). However, the 
use of plastics in IV therapy did not come until 1950 when Dr. David Massa, 
a resident in anesthesiology, created the first over-the-needle IV cannula 
which later became the famous “Rochester plastic needle” (Rivera et al., 
2005).  
 The landmark discovery of the over-the-needle IV cannula design 
sparked an instant revolution in IV therapy. However, it was only the doctors 
who were allowed to perform IV cannulation in extremely high standards. It 
was not until 1973 when Plumer became the first nurse to administer IV 
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therapy (Rivera et al., 2005). From then on, the evolution of IV catheters 
underwent numerous improvements. 
 Presently, IV therapy is used for hydration, blood transfusion, 
parenteral nutrition, and medication administration. More than 90 percent of 
inpatients undergo IV therapy (Corrigan, 2010). IV catheters are often 
needed for at least a week or so; however, they frequently fail before the 
treatment is completed because of phlebitis (Rickard et al., 2009).  CDC 
endorses the routine replacement of IV catheters in adults to not more than 
every 3-4 days to lessen the possibility of developing phlebitis and infection 
(CDC, 2011).  Remarkably, CDC does not recommend the routine 
replacement of IV catheters in high-risk devices (arterial, hemodialysis, and 
central venous catheters) or in kids since this does not avert infection 
(O’Grady et al., 2011). Although there is evidence from observational 
studies linking the increasing length of catheter dwell time with the 
incidence of phlebitis (Mestre Roca et al., 2012; Malach et al., 2006; Powell, 
Tarnow, & Perucca, 2008), other studies do not coincide with this finding 
(Sterba, 2001; Idvall & Gunningberg, 2006; Ho & Cheung, 2012; Webster, 
Osborne, Rickard, & Hall, 2010).  
 If the area of catheter insertion was taken into consideration as a 
determining factor for phlebitis, several studies showed different results. One 
research in particular showed there was no statistically significant difference 
between peripheral IV catheters inserted in the ward and in the emergency 
room in terms of phlebitis rates (Salgueiro-Oliveira, Veiga, & Parreira, 
2012). In contrast to the previous study, a study in Nepal found that the 
incidence of phlebitis rates in the hospital were higher in the medical ward, 
surgical ward, emergency room, operation theater, and OB-GYNE area 
compared with the rest of the hospital areas (Sing, Bhandary, & Pun, 2008). 
Another study compared the population between the medical and surgical 
outpatient departments (OPD) in India and showed that the medical OPD had 
higher phlebitis rates while the surgical OPD had higher infiltration rates 
(Saini, Agnihotri, Gupta, & Walia, 2011).  
 Gender and age were also considered and showed that women and 
older patients were more likely to develop peripheral IV complications 
(Kagel & Rayan, 2004; Ascoli, De Guzman, & Rowlands, 2012). Other 
studies linked the presence of IV complications with an increased length of 
hospital stay (Waitt, Waitt, & Pirmohamed, 2004; Marschall et al., 2014).  
 White (2001) reported that adults showed that 40 percent of the 
phlebitis cases occurred in patients with orthopedic and respiratory 
diagnoses. Even if the sample was small, it was sufficient to demonstrate a 
significant correlation between phlebitis and the patients’ diagnoses. Rickard 
et al. (2012) conducted a study involving diagnoses and comorbidities as 
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factors but there were no conclusions made on the relationship between the 
variables and phlebitis.  
 Katsogridakis, Seshadri, Sullivan, & Waltzman (2008) determined 
the success rates of multiple cannulations in children inserted by physicians, 
nurses, and IV clinicians at a range 23 percent, 44 percent, and 98 percent 
respectively. It was also found out that nurses who are older and have more 
experience in IV insertions had significantly greater success at cannulation 
than the younger and less-experienced ones (Jacobson & Winslow, 2005). 
Data on successful cannulation in children showed 53 percent success on the 
first attempt up to 91 percent on the fourth attempt on different IV sites 
(Lininger, 2003). The results of that study led to a standard of practice in that 
hospital with nurses having no more than four attempts at insertion. There is, 
however, one noteworthy study that linked the nursing profession with 
phlebitis and infiltration rates as high as 85 percent (Saini, Agnihotri, Gupta, 
& Walia, 2011).  
 The most common sites identified with peripheral IV complications 
are the forearm, hand, wrist, antecubital fossa (Kagel & Rayan, 2004), and 
joint (Sing, Bhandary, & Pun, 2008). Currently, CDC (2011) recommends 
the use of the upper-extremity for catheter insertion in grownups. In the 
event that an IV catheter is in the lower extremity, it must be transferred to 
an upper extremity in the earliest possible time to decrease complications. It 
is also suggested that the non-dominant hand be used to diminish accidental 
damage to the IV site (Dougherty & Lister, 2005), starting with the most 
distal area and moving up as needed (Hadaway & Millam, 2005). In 
addition, INS (2000) advocates that each succeeding IV cannula should be 
inserted in a site close to the last one.  
 With regard to catheter gauge, several studies involved their 
differentiation as part of the characteristics of an IV catheter (Webster, 
Lloyd, Hopkins, Osborne, & Yaxley, 2007; Van Donk, Rickard, McGrail, & 
Doolan, 2009; Rickard et al., 2012). There are a few researches though who 
found out that catheter gauge has no influence on the development of 
phlebitis (Abbas, de Vries, Shaw, & Abbas, 2007; Salgueiro-Oliveira, Veiga, 
& Parreira, 2012; Uslusoy & Mete, 2008). The current recommendation, 
however, is that the patient’s status and the type of infusate should be 
considered before selecting a catheter gauge (Hadaway & Millam, 2005).  
 The material used for the creation of IV catheters also exert influence 
on the incidence of phlebitis. Polyurethane catheters, also known as 
“Teflon”, were associated with a decreased likelihood of infection compared 
with polyvinyl chloride or polyethylene catheters (O’Grady et al., 2002). 
Although steel needles have similar rates of infectious complications with 
Teflon, CDC (2011) recommends the use of the latter in peripheral IV 
cannulations because it has lower incidences of infiltration. Newer versions 
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of the polyurethane in the market, however, have been associated with a 30-
45 percent drop in the incidence of peripheral vein thrombophlebitis when 
compared with the previous type of Teflon (Tagalakis, Kahn, Libman, & 
Blostein, 2002).  
 INS (2011) acknowledges the role of the infusate in the development 
of infiltration or extravasation. Salgueiro-Oliveira, Veiga, and Parreira 
(2012) found out that potassium chloride and antibiotics increased the 
likelihood of phlebitis by 1.95 and 1.92 times respectively. Blood, however, 
was not found to be statistically significant in increasing the incidence of 
phlebitis as found out by Singh, Bhandary, and Pun (2008). As for the 
number of drug administrations, Uslusoy and Mete (2008) showed that 
medications given at least four times daily doubled the risk of phlebitis 
compared with medications given one to three times daily.  
 An exhaustive review of the current literature on the comparison 
between routine and clinically indicated change of peripheral intravenous 
catheters revealed several studies. Six (6) of the studies were randomized 
controlled trials with population sizes ranging between 47 and 1,885. Four 
(4) of the researches were run in single-center, acute inpatient locales 
(Barker, Anderson, & Macfie, 2004; Webster et al., 2007; Webster et al., 
2008; Rickard, McCann, Munnings, & McGrail, 2010). One was done in a 
residential setup (Van Donk et al., 2009) while the other one was a multi-
center study of three hospitals (Rickard et al., 2012). Three trials compared 
routine catheter changes (every 3-4 days) with clinically indicated changes 
(Van Donk et al., 2009; Rickard et al., 2010; Rickard et al., 2012) but only 
one trial had 48 hour changes compared with clinical indications (Barker et 
al., 2004). All of the results were strikingly similar in that they found no 
evidence of benefit for routine peripheral catheter changes over clinical 
indication changes. These findings coincide with earlier studies which 
showed that extending the duration of peripheral intravenous catheterization 
did not increase the risk for phlebitis (White, 2001) and lowered the cost and 
clinician time consumed (Catney et al., 2001; O’Grady et al., 2002).  
 Data suggests the possibility and benefit of extending peripheral 
intravenous sites for more than 72 hours; however, all of the researches were 
conducted outside of the country – mostly Australia (Webster et al., 2007; 
Webster et al., 2008; Van Donk et al., 2009; Rickard et al., 2010; Rickard et 
al., 2012).  Thus, it is essential to find out if the findings of the previous 
studies will be replicated in the present research locale. Furthermore, 
pursuing this research will not only improve evidence for clinical practice 
but also evaluate the current practice of replacing peripheral IV catheters 
every 3 days. With the addition of more variables, this research aims to add 
new knowledge to the current literature on IV catheter replacement.  
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Research Methodology 
Research Design.  
 This research employed a two-group, post-test only, randomized 
experimental design wherein research participants were equally but 
randomly assigned to the standard replacement or control group and the 
clinically indicated replacement or experimental group. The control group 
had their peripheral IV catheters changed on a standard basis (every 72 hours 
or 3 days) while the experimental group had their peripheral IV catheters 
replaced on a clinical need basis (presence of phlebitis, infiltration, and 
localized site infection).  
 The randomization ensured that the two groups were the identical in 
terms of attributes thereby making a pretest unlikely necessary. Since the two 
groups were equivalent from the start, any difference between them in terms 
of dependent variables is most likely attributed to the effect of the 
independent variable (Trochim, 2000). 
 
Research Locale.  
 The study was conducted in Hospital A – a level 4, tertiary hospital 
situated in Cebu City, Central Philippines. Although the medical institution 
consisted of several wards, the foci of the study was placed on the Medical 
and Surgical Wards.  
Research Participants.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Flow of research treatments through a two-group, post-
test only, randomized experimental design 
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 Figure 2 illustrates the flow in how actual research participants were 
randomized and selected. There were 80 patients who qualified based on the 
selection criteria and all of them were considered as research participants.  In 
essence, a complete enumeration was resorted to; thereby no randomization 
was employed for the choice of the research participants.  
 The research was implemented for a period of 30 days. The inclusion 
criteria drafted patients who were: (a) admitted in the Medical or Surgical 
Ward, (b) 18 years old and above, and (c) projected to have a peripheral IV 
catheter in place for a minimum of 96 hours. On the other hand, the 
exclusion standards disregarded patients who: (a) were 
immunocompromised, (b) had an IV in place for more than 48 hours, (c) had 
a planned removal of IV in less than 24 hours, (d) underwent blood 
transfusion using the same IV catheter, and (e) had hypersensitivity to the IV 
catheter. The participants who passed both criteria were then divided equally 
into two groups with 40 members each using randomization. A total of 99 
peripheral IV catheters were inserted in the control group while only 69 were 
inserted in the experimental group.  
 
Research Instrument 
 A structured outcome assessment form was employed for this study 
adapted from the Peripheral IV Assessment Form of North York General 
Hospital (NYGH). We modified it to capture all data related to the variables 
under study.  The said adapted research instrument was available online free 
of charge.  
 
Data Gathering Procedure 
 After consent was obtained, data involving the patient’s peripheral IV 
catheter was collected at least once daily, through an exhaustive chart review 
using the Modified Peripheral IV Assessment Form. Any member of the 
healthcare staff (nurse, physician, or intern) was responsible for all the IV 
cannulations. We had no involvement in the manner of inserting, securing, or 
removing the IV catheters; hence, a cannulation protocol could not be 
established.  
 The peripheral IV catheter was removed only in the presence of a 
clinical complication (phlebitis, infiltration, and localized site infection) and 
reinserted if required by the physician. During the course of the study, as 
researchers, we made ourselves available to the participants and the 
healthcare staff through mobile phone contacts. 
 
Data Analysis  
 To determine the prevalence rate of phlebitis, infiltration, and 
localized site infection between both groups, a descriptive analysis was used. 
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On another note, the Chi-square test of independence was utilized to assess 
the degree of influence the moderating and mediating variables have on the 
outcome variables – phlebitis and infiltration. 
 On the other hand, the T-test of two independent samples was used to 
determine if there was a significant difference between the standard 
replacement group and the clinically indicated replacement group with 
regard to age, length of hospital stay, and experience of nurse as IV therapist. 
The same statistical test was employed in determining the significant 
difference between the two groups with regard to the first onset of infiltration 
and phlebitis. Statistical treatments were carried out using MS Excel for 
Windows and the Minitab (Version 17, Free Trial) software. 
 
Method of Verification 
 Every step of the research underwent rigorous steps to ensure that it 
was the actual representation of what transpired. First, we reviewed the chart 
and obtained the necessary data using the Modified Peripheral IV 
Assessment Form. The information obtained from the chart review was then 
verified by the patient if correct. After the initial confirmation, a second 
verification was done by the nurses of the unit. They certified that the data 
recorded on the patients’ charts were true and accurate to the best of their 
knowledge. The third and last verification was performed by the charge 
nurse or the head nurses of the unit through validation of the nurses’ 
documentation to ensure that no data manipulation took place.  
 
Ethical Considerations 
 To ensure that a patient’s right to accept or refuse participation in a 
research was protected, a consent was obtained within 24 hours prior to the 
subject’s enrollment in the study. Confidentiality was also regarded as 
equally important; hence we took careful steps to guarantee that no name or 
identity was disclosed to the public without the patient’s consent. Moreover, 
care was exercised when naming brands of the peripheral IV catheters during 
the course of the research to avoid bias and unintentional marketing. Finally, 
safety of the research participants was our topmost priority; thus, any form of 
clinical complication (phlebitis, infiltration, and localized site infection) 
arising from the presence of a peripheral IV device warranted the need for its 
termination. Reinsertion of a new IV catheter was only done if clinically 
required by the physician.  
 
Results and Discussion 
 In this chapter, we present the outcomes of the study by discussing 
the findings substantiated with interpretations and implications, then linking 
them to the literature reviews. 
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Prevalence Rates of Phlebitis, Infiltration, and Localized Site Infection 
between Control and Experimental Groups 
 Table 1 shows that a total of 168 peripheral IV catheters were 
inserted to 80 research participants; 99 of which belonged to the control 
group while the remaining 69 were part of the experimental group.  
Peripheral IV catheters in the control group were changed every 3 days, thus 
explaining why there were more catheters inserted in the control group 
compared with the experimental group. Of the four possible outcomes 
(normal, phlebitis, infiltration, and localized site infection), the outcome with 
the highest count was “normal” covering 83 percent of the control group and 
58 percent of the experimental group. This suggests that more than half of 
the time, a peripheral IV catheter inserted into a patient will not develop any 
complications. On the contrary, the outcome with the lowest count was 
“localized site infection” with only a single case in each group. Based on the 
data, we can assume that localized site infection is a rare complication of 
intravenous therapy unlike phlebitis and infiltration. These findings coincide 
with the results of similar studies involving peripheral IV catheters (Webster 
et al., 2008; Rickard et al., 2010). 
 
Table 1.  Prevalence rates of phlebitis, infiltration and localized site infection between 
control and experimental groups 
Area Outcome variables 
Standard 
replacemen
t (control 
group) 
Percen
t 
(%) 
Clinical 
replacement 
(experimental 
group) 
Percen
t 
(%) 
Surgical 
Ward 
(Male) 
Normal 32 88.89 11 52.38 
Phlebitis 4 11.11 5 23.81 
Infiltration - - 5 23.81 
Localized Site 
Infection 
- - - - 
Subtotal 36 100.00 21 100.00 
Surgical 
Ward 
(Female
) 
Normal 18 69.23 13 52.00 
Phlebitis 3 11.54 8 32.00 
Infiltration 4 15.38 4 16.00 
Localized Site 
Infection 
1 3.85 - - 
Subtotal 26 100.00 25 100.00 
Medical 
Ward 
(Male & 
Female) 
Normal 32 86.49 16 69.57 
Phlebitis 5 13.51 3 13.04 
Infiltration - - 3 13.04 
Localized Site 
Infection 
- - 1 4.35 
Subtotal 37 100.00 23 100.00 
All 
Wards 
Normal 82 82.83 40 57.97 
Phlebitis 12 12.12 16 23.19 
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Infiltration 4 4.04 12 17.39 
Localized Site 
Infection 
1 1.01 1 1.45 
Total 99 100.00 69 100.00 
 
 Further investigation reveals that the experimental group had the 
highest number of “Phlebitis” and “Infiltra-tion” with corresponding rates of 
23.19 percent (16) and 17.39 percent (12) compared with the control group 
who only had 12.12 percent (12) and 4.04 percent (4). Adding up all the rates 
of complications in both groups would reveal that the experimental group 
had a higher incidence of complication at 42.03 percent, compared with the 
control group who only had rate of 17.17 percent. This suggests that 
changing peripheral IV sites every 72 hours or 3 days were associated with 
lesser chances of developing phlebitis, infiltration, and localized site 
infection. This result agrees with the assertion of CDC (2011) that routine 
replacement of IV catheters reduces the risk of infection and phlebitis.  
 
Frequency of Phlebitis and Infiltration With Regard to Moderating and 
Mediating Variables 
 Table 2 illustrates the results of the Chi-square analysis between the 
moderating and mediating variables, and frequency counts of phlebitis and 
infiltration. The other complication – localized site infection, was excluded 
from the table because it could not be statistically treated for having values 
less than the minimum number required by the test. The outcome variables – 
Phlebitis and Infiltration, were further subdivided into 2 groups (“With” and 
“Without”) to clearly delineate the occurrence of the complications. 
Furthermore, all data were dichotomized to give the readers a better grasp of 
the variables under study. A total of 168 peripheral IV catheters were 
inserted in 80 patients for a period of 30 days.  
 Table 2 further reveals that only 3 out of the 15 identified moderating 
and mediating variables were found to have statistically significant results. 
The first significant variable on the list is the length of hospital stay, 
expressed in either 4-6 days or 7-14 days. It was found out that patients who 
stayed for 7-14 days had a higher rate of phlebitis (18 out of 77 cases or 
23.38 percent) and infiltration (12 out of 77 cases or 15.58 percent) 
compared with those who only remained for 4-6 days. This suggests that the 
longer a patient stays in the hospital, the higher is the likelihood of 
developing peripheral IV complications. The findings are similar with 
previous researches which showed that an increased length of hospital stay is 
associated with the presence of more IV complications (Waitt, Waitt, & 
Pirmohamed, 2004; Marschall et al., 2014). 
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Table 2.  Frequency of phlebitis and infiltration with regard to moderating and mediating 
variables 
MODERATING & 
MEDIATING VARIABLES 
Phlebitis 
(n = 168) 
CHI-SQUARE TEST (α = 0.05) Infiltration 
(n = 168) CHI-SQUARE TEST (α = 0.05) 
With Without X2-Value df P-Value With Without X2-Value df P-Value 
Ward 
Medical 8 53 
0.870ns 1 0.351 
3 58 
2.358ns 1 0.125 
Surgical 20 87 13 94 
Age 
45 and 
below 
16 70 
0.476ns 1 0.490 
10 76 
0.905ns 1 0.341 
46 and 
above 
12 70 6 76 
Gender 
Male 11 78 
2.528ns 1 0.112 
7 82 
0.604ns 1 0.437 
Female 17 62 9 70 
Length of 
Hospital Stay 
4-6 days 10 81 
4.608* 1 0.032 
4 87 
6.060* 1 0.014 
7-14 days 18 59 12 65 
Diagnosis 
Medical 8 53 
0.870ns 1 0.351 
3 58 
2.358ns 1 0.125 
Surgical 20 87 13 94 
Number of 
Comorbidities 
None 22 118 
1.494ns 1 0.222 
15 125 
0.904ns 1 0.342 
One 6 17 1 22 
Profession of 
IV Therapist 
Nurse 25 122 
0.004ns 1 0.947 
12 135 
4.087* 1 0.043 
Physician 3 14 4 13 
Experience as 
IV Therapist 
(Nurse) 
2 years 14 93 
4.301* 1 0.038 
10 97 
0.099ns 1 0.753 
3 years 8 19 2 25 
Number of 
Cannulation 
Attempts on 
Same Vein 
One Attempt 28 132 
1.680ns 1 0.195 
15 145 
0.086ns 1 0.769 
Two 
Attempts 
0 8 1 7 
Location of 
IV Site 
Cephalic 11 45 
0.800ns 1 0.371 
5 51 
0.184ns 1 0.668 Dorsal 
Metacarpal 
14 85 11 88 
Laterality of 
IV Site 
Right 15 72 
0.043ns 1 0.836 
8 79 
0.023ns 1 0.881 
Left 13 68 8 73 
IV Catheter 
Size 
G20 14 62 
0.183ns 1 0.668 
4 72 
1.705ns 1 0.192 
G18 13 69 9 73 
IV Catheter 
Type 
Polyurethane 13 71 
0.171ns 1 0.679 
9 75 
0.276ns 1 0.599 
Teflon 15 69 7 77 
Type of IV 
Fluid 
PNSS 15 64 
0.797ns 1 0.372 
6 73 
1.057ns 1 0.304 
PLR 11 69 10 70 
Type of IV 
Medication 
Antibiotic 19 96 
0.078ns 1 0.781 
11 104 
0.209ns 1 0.648 
Anti-ulcer 22 101 14 109 
df – degree of freedom, ns - not significant, * - significant at α = 0.05 
 
 The second salient variable in the table is the profession of the IV 
therapist. While there is no significant relationship found between profession 
and the occurrence of phlebitis, the opposite is seen in infiltration. Data 
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reveal that peripheral IV catheters inserted by physicians had a higher rate of 
infiltration (4 out of 17 cases or 23.53 percent) compared with those inserted 
by nurses (12 out of 147 cases or 8.16 percent). One possible reason for this 
is that nurses undergo formal classes on IV therapy training delivered by 
ANSAP before they could care for patients with IV devices, whereas 
physicians learn it from actual on-the-job training. As a result, nurses are 
more inclined to follow established principles of asepsis compared with other 
healthcare providers who do not have any formal IV therapy training. This 
finding is reassuring in a sense that it refutes the result of a previous study by 
Saini, Agnihotri, Gupta, and Walia (2011) wherein nurses were accounted 
for phlebitis and infiltration rates as high as 85 percent. 
 The last variable which shows significant result is the experience of 
the IV therapist. In this category, only the nurses’ experience was considered 
since values belonging to the physicians were well below the minimum 
frequency count required for Chi-square test. On closer assessment, data 
show that nurses who had 2 years of experience were found to have lower 
incidence of phlebitis (14 out of 107 cases or 13.08 percent) compared with 
those who had 3 years of experience (8 out of 27 cases or 29.63 percent). A 
tentative explanation for this is that nurses who have 3 or more years of 
experience might have already forgotten the policies and procedures that 
were taught to them during their IV therapy training. This strengthens the 
mandatory requirement of ANSAP to have nurses undergo refresher courses 
on IV therapy training every 3 years. The remaining variables did not yield 
any significant influence on the occurrence of phlebitis and infiltration (P-
Value > 0.05). 
Difference between Control and Experimental Groups on Phlebitis With 
Regard to Moderating and Mediating Variables 
 
Table 3.  Difference between control and experimental groups on phlebitis with regard to 
moderating and mediating variables 
Variable Group n Mean SD 
T-
Value 
df 
P- 
Value 
Age (Years) 
Control 12 48.75 21.00 
1.250ns 18 0.227 
Experimental 16 39.94 14.28 
Length of Hospital 
Stay (Days) 
Control 12 6.92 2.11 
1.160ns 22 0.259 
Experimental 16 7.81 1.87 
Experience of Nurse as 
IV Therapist (Years) 
Control 11 2.27 0.65 
0.490ns 21 0.627 
Experimental 14 2.14 0.66 
 
 Table 3 depicts the results of the T-test of mean difference between 
the standard replacement group and the clinically indicated replacement 
group with regard to age, length of hospital stay, and experience of nurses as 
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IV therapist. Only the 3 abovementioned variables were included since the 
rest of the moderating and mediating variables were nominal in nature and 
could not be subjected to the statistical test. In addition, the table excluded 
the outcome variables – infiltration and localized site infection, because they 
each had counts that do not yield a Standard Deviation (SD) value. 
 From the entire 168 peripheral IV catheters that were inserted in 80 
research participants for a period of 30 days, 28 cases of phlebitis were taken 
into consideration. 12 out of the 28 cases belonged to the control group while 
the remaining 16 cases were under the experimental group. The mediating 
variable “experience of nurse as IV therapist” has a different count since 
only 25 out of the 28 phlebitis cases were inserted by the nurses. 11 out of 
the 25 cases belonged to the control group while the remaining 14 cases were 
under the experimental group. The remaining 3 phlebitis cases inserted by 
the physicians were omitted since the figures were not sufficient to generate 
an SD value. 
 Based on the tabulated data, it can be seen that there is no significant 
difference between the control and experimental groups with regard to age, 
length of hospital stay, and experience of nurse as IV therapist (P-Values > 
0.05).  This suggests that both groups have an equal chance of developing 
phlebitis regardless of age, length of hospital stay, and experience of nurse as 
IV therapist. 
 
Difference between Control and Experimental Groups on the First  
 
Table 4. Difference between control and experimental groups on the first onset of outcome 
variables 
Outcome 
Variable 
Group n Mean SD T-Value df 
P-
Value 
Phlebitis 
(Days) 
Control 10 2.34 0.73 
0.430ns 17 0.673 
Experimental 10 2.21 0.62 
Infiltration 
(Days) 
Control 2 2.25 1.34 
0.040ns 1 0.974 
Experimental 9 2.21 0.63 
 
Onset of Outcome Variables 
 Table 4 illustrates the T-test of mean difference between the standard 
replacement group and the clinically indicated replacement group on the first 
onset of phlebitis and infiltration. The last outcome variable – Localized Site 
Infection, was not included because it had numerical data that were not 
adequate to yield an SD value. Only the first instance of complication was 
taken into consideration so as to determine the average length of time it took 
one peripheral IV site to develop phlebitis or infiltration without the biases 
that may occur if the subject had previous similar cases. 
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 Out of the 168 peripheral IV catheters that were inserted in 80 
research participants over a course of 30 days, 20 developed into phlebitis 
while 11 advanced to infiltration – both of which developed on the first 
occasion. The 20 cases of phlebitis were equally divided between the control 
and experimental groups with 10 counts each. On the other hand, 2 out of the 
11 infiltration cases belonged to the control group while the remaining 9 
were under the experimental group.  
 Analysis of the data show that the average number of days to develop 
phlebitis was 2.34 for the standard replacement group and 2.21 for the 
clinically indicated replacement group. Although both groups have similar 
values, there is no significant difference between them. Likewise, the same 
insignificant relationship can be found for infiltration between both groups 
(2.25 days for the control group versus 2.21 days for the experimental 
group). 
 Although the average time it took for phlebitis or infiltration to occur 
was less than 3 days, the findings suggest that standard replacement of 
peripheral IV catheters every 3 days has no benefit over clinically indicated 
changes (P-Values > 0.05). This outcome reinforces several studies which 
revealed that there was no significant difference between standard and 
clinically indicated changes with regard to phlebitis and infiltration (Webster 
et al., 2007; Webster et al., 2008; Van Donk et al., 2009; Rickard et al., 
2010; Rickard et al., 2012). 
 
Proposed New IV Replacement Guidelines 
 Based on the results gathered from the study, we propose the 
following new IV replacement guidelines to be adopted by hospitals: 
1. Replacing peripheral IV catheters on a clinical-need, rather than a 
routine basis to lessen the possibility of developing phlebitis and infiltration 
in adults is a viable option (Webster et al., 2007; Webster et al., 2008; Van 
Donk et al., 2009; Rickard et al., 2010; Rickard et al., 2012). 
2. When rotating sites of peripheral IV catheters based on clinical 
indications is followed, routine IV site assessment should be done to 
minimally include the following factors: patient’s subjective data, visual 
evaluation, and palpation of the IV site (INS, 2011).  
3. The frequency of site assessment should be: 
a. No less than every 4 hours for patients receiving non-blistering or 
non-irritating solutions (INS, 2011);  
b. At best every 1-2 hours for severely ill patients (INS, 2011); and  
c. At least every 5-10 minutes for patients receiving intermittent 
vesicant solutions and vasoconstrictor agents (INS, 2011). 
4. Each organization should adopt a standardized scale in assessing 
phlebitis (Gallant & Schultz, 2006) and infiltration (INS, 2006b). 
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5. For cases involving infusion-related infections, culture should be 
done on blood specimens, the tip of the IV catheter, and the IV site using 
aseptic technique (INS, 2006c).  
6. Appropriate documentation should be done to include patient 
assessment, complications, and side-effects associated with infusion therapy 
(INS, 2006c). 
7. Each organization should establish protocols in the care of vascular 
access devices (i.e. peripheral IV catheters) to avoid complications (2006c).  
 
Conclusions and Recommendations 
 In light of the research findings, we conclude that the risk of 
developing phlebitis and infiltration is not increased when peripheral IV 
catheters are replaced on a clinical-need rather than on a routine basis among 
adult patients.  Length of hospital stay has bearing on the development of 
phlebitis and infiltration; whereby the longer a patient stays in the hospital 
with a peripheral IV catheter, the higher is the likelihood of developing 
phlebitis and infiltration. Moreover, when peripheral IV catheters are 
inserted by a physician, there is an increased chance of developing 
infiltration. Arguably, the length of experiences among nurses is associated 
with the development of phlebitis. Other variables considered in the study 
(ward, age, gender, diagnosis, comorbidities, cannulation attempt, location 
and laterality of IV site, IV catheter size, IV catheter type, and type of IV 
fluid and medication) have no relevance on the development of phlebitis or 
infiltration. 
 Hospitals should consider adopting new guidelines wherein 
peripheral IV catheters are replaced only in the presence of complications – 
phlebitis and infiltration. Consequently, unnecessary pain would be avoided 
and potential savings may be promoted for patients with peripheral IV 
catheters changed on a clinical need basis. 
 Similar studies may be conducted involving larger population 
samples for a prolonged duration of time to eliminate the insufficiency of 
values in certain data subsets such as the case of the outcome variable 
“localized site infection.” Moreover, the study should include blood and 
device cultures if they wish to develop an accurate connection between the 
presence of a peripheral IV catheter and the development of localized site 
infection. Finally, it would be a welcome addition if cost, pain level, and 
patient satisfaction could be measured as one of the outcome variables in the 
study. This would greatly help evaluate the patient’s response in relation to 
the application of the hospital IV replacement policy.   
 
 
 
European Scientific Journal June 2017 edition Vol.13, No.18 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
 
166 
References: 
1. Abbas, S.Z., de Vries, T.K., Shaw, S., & Abbas, S.Q. (2007). Use and 
complications of peripheral vascular catheters: a prospective study. 
British Journal of Nursing, 16(11), 648-652. Retrieved from 
http://www.ncbi. nlm.nih.gov 
2. Ascoli, G.B., De Guzman, P.B., & Rowlands, A. (2012).Peripheral 
intravenous catheter complication rates between those indwelling > 
96 hours to those indwelling 72–96 hours: a retrospective 
correlational study. International Journal of Nursing, 1(2), 7-12. 
Retrieved from www.ijnonline.com 
3. Barker, P., Anderson, A.D.G., & Macfie, J. (2004). Randomised 
clinical trial of elective re-siting of intravenous cannulae. Annals of 
the Royal College of Surgeons of England, 86(4), 281–3. 
doi:10.1308/147870804317 
4. Catney, M.R., Hillis, S., Wakefield, B., Simpson, L., Domino, L., 
Keller, S., Wagner, K. (2001). Relationship between peripheral 
intravenous catheter dwell time and the development of phlebitis and 
infiltration. Journal of Infusion Nursing, 24(33), 2-41. 
doi:10.1097/00129804-200109000-00008 
5. Centers for Disease Control and Prevention. (2011). Guidelines for 
the Prevention of Intravascular Catheter-Related Infections. 
Retrieved from http://www.cdc.gov 
6. Corrigan, A. (2001). History of intravenous therapy. In Hankins, J., 
Waldman Lonsway, R.A., Hedrick C., & Perdue, M. (Eds.). Infusion 
therapy in clinical practice (2nd ed.). Philadelphia, PA: WB 
Saunders 
7. Corrigan, A. (2010). Infusion nursing as a specialty. In Alexander, 
M., Corrigan, A., Gorski, L., Hankins, J., & Perucca, R. (Eds.). 
Infusion nursing an evidence-based approach (3rd ed.). St Louis, MI: 
Saunders Elsevier 
8. Doellman, D., Hadaway, L., Bowe-Geddes, L.A., Franklin, M., 
LeDonne, J., Papke-O’Donnell, L., Stranz, M. (2009). Infiltration and 
extravasation: update on prevention and management. Journal of 
Infusion Nursing, 32(4), 203-211. doi:10.1097/NAN.0b013e 
3181aac042 
9. Dougherty, L. (2008). IV therapy: recognizing the differences 
between infiltration and extravasation. British Journal of Nursing, 
17(14), 896-901. http://dx.doi.org 
10. Dougherty, L., & Lister, S. (2005). The royal marsden hospital 
manual of clinical nursing procedures (6th ed.). Oxford, UK: 
Blackwell Publishing 
European Scientific Journal June 2017 edition Vol.13, No.18 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
 
167 
11. Dychter, S., Gold, D., Carson, D., & Haller, M. (2012). Intravenous 
Therapy: A Review of Complications and Economic Considerations 
of Peripheral Access. Journal of Infusion Nursing, 35, 84-91. 
doi:10.1097/NAN. 0b013e31824237ce 
12. Felts, J.H. (2000). Richard Lower: anatomist and physiologist. 
Annals of Internal Medicine, 132(5), 420-423. Retrieved from 
http://acces.ens-lyon.fr 
13. Gallant, P., & Schultz, A.A. (2006). Evaluation of a visual infusion 
phlebitis scale for determining appropriate discontinuation of 
peripheral intravenous catheters. Journal of Infusion Nursing, 29(6), 
338-345. Retrieved from http://journals.lww.com 
14. Ho, K.H., & Cheung, D.S. (2012). Guidelines on timing in replacing 
peripheral intravenous catheters. Journal of Clinical Nursing, 21, 
1499–506. doi:10.1111/j.1365-2702.2011. 03974.x 
15. Idvall, E., & Gunningberg, L. (2006). Evidence for elective 
replacement of peripheral intravenous catheter to prevent 
thrombophlebitis: a systematic review. Journal of Advanced Nursing, 
55, 715–22. doi:10.1111/j.1365-2648.2006.03962.x 
16. Infusion Nurses Society. (2000). Infusion nursing standards. Journal 
of Intravenous Nursing. 23(6S), 1-88. Retrieved from 
www.journalofinfusionnursing.com 
17. Infusion Nurses Society. (2006a). Infusion nursing standards of 
practice. Journal of Infusion Nursing. Hagerstown, MD: JP 
Lippincott. Retrieved from www.journalofinfusion nursing.com 
18. Infusion Nurses Society. (2006b). Infusion nursing standards of 
practice. Journal of Infusion Nursing, 29(1S), S59-S62. Retrieved 
from www.journalofinfusionnursing.com 
19. Infusion Nurses Society. (2006c). Infusion nursing standards of 
practice. Journal of Infusion Nursing. Cambridge, MA: INS and 
Becton Dickinson. Retrieved from www.journalofi 
nfusionnursing.com 
20. Infusion Nurses Society. (2011). Infusion nursing standards of 
practice. Journal of Infusion Nursing, 34(1S), Retrieved from 
www.journalofinfusionnursing.com 
21. Ingram, P. & Lavery, I. (2005). Peripheral intravenous therapy: key 
risks and implications for practice. Nursing Standard, 19(46), 55-64. 
Retrieved from http://www.ncbi.nlm.nih.gov 
22. Jacobson, A.F., & Winslow, E.H. (2005). Variables influencing 
intravenous catheter insertion difficulty and failure: An analysis of 
339 intravenous catheter insertions. The Journal of Acute and Critical 
Care, 34(5), 345-359 
European Scientific Journal June 2017 edition Vol.13, No.18 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
 
168 
23. Kagel, E.M., & Rayan, G.M. (2004). Intravenous catheter 
complications in the hand and forearm. Journal of Trauma-Injury 
Infection & Critical Care, 56(1), 123-7 
24. Katsogridakis, Y.L., Seshadri, R., Sullivan, C., & Waltzman, M.L. 
(2008). Veinlite transillumination in the pediatric emergency 
department: a therapeutic interventional trial. Pediatric Emergency 
Care, 24(2), 83-8. doi: 10.1097/PEC.0b013e318163db5f 
25. Lininger, R.A. (2003). Pediatric peripheral IV insertion success rates. 
Pediatric Nursing, 29(5), 351-354. Retrieved from 
http://europepmc.org 
26. Maki, D.G. (2008). Improving the safety of peripheral intravenous 
catheters. British Medical Journal, 337, a630. doi:10.1136/bmj.a630 
27. Malach, T., Jerassy, Z., Rudensky, B., Schlesinger, Y., Broide, E., 
Olsha, O., Raveh, D. (2006). Prospective surveillance of phlebitis 
associated with peripheral intravenous catheters. American Journal of 
Infection Control, 34, 308-312. Retrieved from 
https://www.docphin.com 
28. Marschall, J., Mermel L.A., Fakih, M., Hadaway, L., Kallen, A., 
O’Grady, N.P., Yokoe, D.S. (2014). Strategies to prevent central 
Line–associated bloodstream infections in acute care hospitals: 2014 
update. Infection Control and Hospital Epidemiology, 35(7). 
doi:10.1086/676533 
29. Mestre Roca, G., Berbel Bertolo, C., Tortajada Lopez, P., Gallemi 
Samaranch, G., Aguilar Ramirez, M.C., Cayla Buqueras, J., 
Martinez, J.A. (2012). Assessing the influence of risk factors on rates 
and dynamics of peripheral vein phlebitis: an observational cohort 
study. Medicina Clinica, 139, 185-91. 
doi:10.1016/j.medcli.2011.12.021 
30. O’Grady, N.P., Alexander, M., Burns, L.A., Dellinger, E.P., Garland, 
J., Heard, S.O., Saint, S. (2011). Guidelines for the prevention of 
intravascular catheter-related infections. American Journal of 
Infection Control, 39(4 suppl 1), S1-34. doi:10.1093/cid/cir257 
31. O’Grady, N.P., Alexander, M., Dellinger, E.P., Gerberding, J.L., 
Heard, S.O., Maki, D.G., Weinstein, R.A. (2002). Guidelines for the 
prevention of intravascular catheter-related infections. Centers for 
disease control and prevention. Morbidity and Mortality Weekly 
Report Recommendations and Reports, 51(RR-10), 1–29. Retrieved 
from http://www.ncbi.nlm.nih.gov 
32. Powell, J., Tarnow, K.G., Perucca, R. (2008). The relationship 
between peripheral intravenous catheter indwell time and the 
incidence of phlebitis. Journal of Infusion Nursing, 31, 39-45. 
doi:10.1097/01.NAN.0000308544. 67744.50 
European Scientific Journal June 2017 edition Vol.13, No.18 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
 
169 
33. Rickard, C.M., McCann, D., Munnings, J., & McGrail, M.R. (2010). 
Routine resite of peripheral intravenous devices every 3 days did not 
reduce complications compared with clinically indicated resite: A 
randomised controlled trial. BioMed Central Medicine, 8, 53. 
doi:10.1186/1741-7015-8-53 
34. Rickard, C.M., Webster, J., Wallis, M.C., Marsh, N., McGrail, M.R., 
French, V., Whitby, M. (2012). Routine versus clinically indicated 
replacement of peripheral intravenous catheters: a randomised 
controlled equivalence trial. Lancet, 380(9847), 1066-74. 
doi:10.1016/S0140-6736(12)61082-4 
35. Rivera, A.M., Strauss, K.W., van Zundert, A., & Mortier, E. (2005). 
The history of peripheral intravenous catheters: how little plastic 
tubes revolutionized medicine. Acta Anaesthesiologica Belgica, 56, 
271-282. Retrieved from http://www.sarb.be 
36. Saini, R., Agnihotri, M., Gupta, A., & Waila, I. (2011). 
Epidemiology of infiltration and phlebitis. Nursing and Midwifery 
Research Journal, 7(1), 22-33. Retrieved from http://medind.nic.in 
37. Salgueiro-Oliveira, A., Veiga, P., & Parreira, P. (2012). Incidence of 
phlebitis in patients with peripheral intravenous catheters: the 
influence of some risk factors. Australian Journal of Advanced 
Nursing, 30(2), 32-39. Retrieved from http://www.ajan.com.au 
38. Singh, R., Bhandary, S., & Pun, K.D. (2008). Peripheral intravenous 
catheter related phlebitis and its contributing factors among adult 
population at KU Teaching Hospital. Kathmandu University Medical 
Journal, 6(4), 443-447. Retrieved from http://www.google.com 
39. Sterba, K.G. (2001). Controversial issues in the care and maintenance 
of vascular access devices in the long-term/subacute care client. 
Journal of Infusion Nursing, 24, 249–54. doi:10.1097/00129804-
200107000-00009 
40. Tagalakis, V., Kahn, S.R., Libman, M., & Blostein, M. (2002). The 
epidemiology of peripheral vein infusion thrombophlebitis: a critical 
review. American Journal of Medicine, 113, 146-151. Retrieved from 
http://www.emergency ultrasoundteaching.com 
41. Trochim, W. (2000). The research methods knowledge base (2nd 
ed.). Cincinnati, OH: Atomic Dog Publishing 
42. Tuffaha, H.W., Rickard, C.M., Webster, J., Marsh, N., Wallis, M., & 
Scuffham, P.A. (2014). Cost-effectiveness analysis of clinically 
indicated versus routine replacement of peripheral intravenous 
catheters. Applied Health Economics and Health Policy, 12(1), 51–8. 
Retrieved from http://www. unboundmedicine.com 
43. Uslusoy, E., & Mete, S. (2008). Predisposing factors to phlebitis in 
patients with peripheral intravenous catheters: a descriptive study. 
European Scientific Journal June 2017 edition Vol.13, No.18 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
 
170 
Journal of the American Academy of Nurse Practitioners, 20(4), 172-
180. doi:10.1111/j. 1745-7599.2008.00305.x 
44. Van Donk, P., Rickard, C.M., McGrail, M.R., & Doolan, G. (2009). 
Routine replacement versus clinical monitoring of peripheral 
intravenous catheters in a regional hospital in the home program: A 
randomized controlled trial. Infection Control and Hospital 
Epidemiology, 30(9), 915–7. Retrieved from 
http://www98.griffith.edu.au 
45. Waitt, C., Waitt, P., & Pirmohamed, M. (2004). Intravenous therapy. 
Postgrad Medical Journal, 80, 1–6. doi:10.1136/pmj.2003.010421 
46. Webster, J., Clarke, S., Paterson, D., Hutton, A., van Dyke, S., Gale, 
C., & Hopkins, T. (2008). Routine care of peripheral intravenous 
catheters versus clinically indicated replacement: randomised 
controlled trial. British Medical Journal, 337, a339. 
doi:10.1136/bmj.a339 
47. Webster, J., Lloyd, S., Hopkins, T., Osborne, S., & Yaxley, M. 
(2007). Developing a Research base for Intravenous Peripheral 
cannula re-sites (DRIP trial). A randomised controlled trial of 
hospital in-patients. International Journal of Nursing Studies, 44(5), 
664–71. Retrieved from http://www.ncbi. nlm.nih.gov 
48. Webster, J., Osborne, S., Rickard, C., & Hall, J. (2010). Clinically-
indicated replacement versus routine replacement of peripheral 
venous catheters. Cochrane Database of Systematic Reviews, 3, 
CD007798. Retrieved from 
http://www98.griffith.edu.au/dspace/bitstream/ handle/ 
10072/32191/62829_1.pdf;sequence=1 
49. White, S.A. (2001). Peripheral intravenous therapy-related phlebitis 
rates in an adult population. Journal of Intravenous Nursing, 24(1), 
19–24. Retrieved from http://www.ncbi.nlm. nih.gov 
  
